Two major pharmaceutical companies will be partnering with the Trump administration’s prescription drug platform, according to a Friday report from Fox Business.
GSK and Amgen have agreed to include their medications on TrumpRX, the prescription drug platform created by President Donald Trump’s administration. The move represents a significant expansion of the government’s prescription drug initiative.
The announcement comes as the administration continues efforts to address prescription drug costs and accessibility for American consumers.
